COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,810 Articles (21,985 medRxiv, 7,825 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Participant experience of Scottish Ballets dance-based long COVID support programme: A mixed methods study
Philip, K. E. J., Burton, A., Lewis, A., Buttery, S. C., Williams, P. J., Polkey, M. I., Fancourt, D., Hopkinson, N. S.
10.1101/2024.10.28.24316302 — Posted: 2024-10-30
A comparative study of multidrug resistant bacteria (MDRB) isolated from various patients in different wards of a hospital during post Covid-19
Ojha, A., Figueiredo, D., Khan, S.
10.1101/2024.10.25.24315976 — Posted: 2024-10-30
Deep generative design of neutralizing nanobodies againstSARS-CoV-2 variants
Huo, L., Tian, T., Xu, Y., Qin, Q., Jiang, X., Huang, Q.
10.1101/2024.10.29.620982 — Posted: 2024-10-30
How the COVID-19 pandemic affected lifestyle and wellbeing factors associated with dementia risk in older adults with Subjective Cognitive Decline and Mild Cognitive Impairment participating in the APPLE-Tree (Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce) in England
Wright, A. M., Demnitz-King, H., Burton, A., Morse, R. M., Alberts, S., Kenten, C., Jeraldo, R. I. E., Poppe, M., Barber, J., Cooper, C.
10.1101/2024.10.28.24316260 — Posted: 2024-10-29
Symptom burden, viral load, and antibody response to ancestral SARS-CoV-2 strain in an outpatient household cohort
Churiwal, M., Tompkins, K., Streeter, G., Litel, C., Mason, S., Lin, K., Muller, M., Chhetri, S., Belvin, T., Basham, C., Whittelsey, M., Rapp, T., Premkumar, L., Cerami, C., Lin, J. T.
10.1101/2024.10.27.24316219 — Posted: 2024-10-29
A mixed-methods analysis of the implementation of a new community long-COVID service during the 2020 pandemic: learning from practice.
Williams, S. L., Beadle, E. L., Wiliams, P., Master, H., Casarin, A. L.
10.1101/2024.10.25.24316101 — Posted: 2024-10-29
Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication
Pfannenstiel, J. J., Duong, M. T. H., Cluff, D., Sherrill, L., Colquhoun, I., Cadoux, G., Thorne, D., Paakkonen, J., Schemmel, N. F., O'Connor, J. J., Saenjamsai, P., Feng, M., Hageman, M., Johnson, D. K., Roy, A., Lehtio, L., Ferraris, D. V., Fehr, A. R.
10.1101/2024.10.28.620664 — Posted: 2024-10-29
Unveiling Humoral and Cellular Immune Responses to SARS-CoV-2 in Head and Neck Cancer: A Comparative Study of Vaccination and Natural Infection in Romania
Marutescu, L., Enea, A., Antoniadis, N.-M., Neculae, M., Costea, D. A., Popa, M., Dragu, E., Codrici, E., Ristoiu, V., Galateanu, B., Hudita, A., Pircalabioru, G. G., Filali-Mouhim, A., Lazar, V., Chifiriuc, C., Grigore, R., Ancuta, P.
10.1101/2024.10.27.620493 — Posted: 2024-10-29
Disruption of molecular interactions between G3BP1 stress granule host protein and nucleocapsid (NTD-N) protein impedes SARS-CoV-2 virus replication
Dhaka, P., Singh, A., Nehul, S., choudhary, s., Panda, P. K., Sharma, G. K., Kumar, P., Tomar, S.
10.1101/2024.10.27.620470 — Posted: 2024-10-28
Real-life observation of wildfire-smoke impaired COVID-19 vaccine immunity
Sanghar, G. K., Teuber, M., Ravindran, R., Keller, E. J., Raffuse, S. M., Hernandez, P. A., Linderholm, A., Echt, G., Franzi, L., Tuermer-Lee, K., Juarez, M., Albertson, T. E., Khan, I., Haczku, A.
10.1101/2024.10.25.24316123 — Posted: 2024-10-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).